The pharmaceutical industry in the United States is experiencing a significant surge in need for Tirzepatide APIs. This potent medication, used to treat type 2 diabetes, has attracted considerable attention from both individuals and healthcare professionals. As a result, numerous manufacturers have emerged as suppliers of Tirzepatide APIs in the US